The present invention provides 3-indazoyl-4-pyridylisothiazoles or a pharmaceutically acceptable salt thereof, pharmaceutical compositions thereof, and methods of using the same, as well as processes for preparing the same, and intermediates thereof.
The present invention provides 3-indazoyl-4-pyridylisothiazoles or a pharmaceutically acceptable salt thereof, pharmaceutical compositions thereof, and methods of using the same, as well as processes for preparing the same, and intermediates thereof.
SCHAEFER H.; GEWALD K., J. PRAKT. CHEM. <JPCE-AO>, 1975, 317, NO 5, 771-778
作者:SCHAEFER H.、 GEWALD K.
DOI:——
日期:——
Synthesis and Antimicrobial Activity of 2-[5-(R-Benzyl)-4-oxo-1,3-thiazolidin-2-ylidene]-3-oxobutanenitrile and [2-(1-Cyano-2-oxopropylidene)-4-oxo-1,3-thiazolidin-5-ylidene]acetic Acid Derivatives
作者:V. Ya. Horishny、V. S. Matiichuk
DOI:10.1134/s1070428020090092
日期:2020.9
The reactions of 2-cyano-3-oxobutanethioamide with ethyl 3-aryl-2-bromopropanoates and dialkyl acetylenedicarboxylates afforded a combinatorial library of new 2-[5-(R-benzyl)-4-oxo-1,3-thtiazolidin-2-ylidene]-3-oxobutanenitrile and [2-(1-cyano-2-oxopropylidene)-4-oxo-1,3-thiazolidin-5-ylidene]acetic acid derivatives. The synthesized compounds were evaluated for antimicrobial activity, and the activity of some derivatives against gram-positiveStaphylococcus aureusATCC 43300 exceeded the activity of ceftriaxone taken as a reference drug.